In late June, Pfizer, the nation’s second-largest pharmaceutical supplier, broke ground on BioPlace, a $250 million, 285,000-sf R&D and process development facility in Chesterfield, Mo.
The new campus, when completed in mid 2019, will house the company’s BioTherapeutics Pharmaceutical Sciences Group, and consolidate more than 450 employees who currently work at multiple locations around St. Louis, including some who working out of leased space in Monsanto’s research center.
Pfizer intends to hire 80 more employees over the coming years to support research at this 32-acre site.
The 32-acre campus will allow Pfizer to consolidate more than 450 of its employees who are scattered at various leased sites around St. Lous. Image: Clayco
The focus of this facility, according to Pfizer’s website, will be on advancing the company’s portfolio in biologics, vaccines, and gene therapy by “developing manufacturing processes and dosage forms applying state-of-the-art analytical technologies.”
The campus will feature a floor plan with flexible laboratory layouts, scientific casework and utility hookups, open office and collaboration spaces, and increased conferencing technologies where researchers can collaborate.
A partnership of Forum Studio and Ewing Cole designed the architecture, landscaping, engineering, interior, and lab process areas for BioPlace’s research and office spaces. Clayco is the design-builder on this project in tandem with its development subsidiary CRG.
Once completed, Pfizer will lease the space from Clayco and CRG, which is providing turnkey build-to-suit services, according to the St. Louis Post-Dispatch.
Related Stories
Laboratories | Feb 10, 2022
Historic building becomes a research science incubator
Svigals + Partners designed the project.
Laboratories | Feb 8, 2022
A new concept for science buildings emphasizes construction speed and design flexibility
The NEXT prototype—devised by Gensler, KPFF, and Buro Happold—also leans toward decarbonization and wellness.
Laboratories | Feb 3, 2022
New veterinarian building is Norway’s largest ever development in the university sector
The project is one of the largest and most complex ever undertaken in Norway.
Laboratories | Jan 28, 2022
3 must-know strategies for developers in today’s life sciences industry
While the life sciences industry had been steadily growing, this growth exploded when the pandemic arrived—and there is no indication that this lightning-fast pace will slow down any time soon.
Laboratories | Jan 17, 2022
A health crisis gives life to life sciences
Construction and renovation projects are heaviest in markets with consistent talent streams.
University Buildings | Jan 11, 2022
Designing for health sciences education: supporting student well-being
While student and faculty health and well-being should be a top priority in all spaces within educational facilities, this article will highlight some key considerations.
Giants 400 | Dec 31, 2021
2021 Science and Technology Sector Giants: Top architecture, engineering, and construction firms in the U.S. S+T facilities sector
HDR, CRB, Jacobs, Skanska USA, and Whiting-Turner Contracting Co. top the rankings of the nation's largest science and technology (S+T) sector architecture, engineering, and construction firms, as reported in the 2021 Giants 400 Report.
Laboratories | Nov 18, 2021
Tapping into the life sciences building boom
Paul Ferro of Form4 Architecture discusses how developers are pivoting to the life sciences sector, and what that means for construction and adaptive reuse.
2021 Building Team Awards | Nov 17, 2021
Caltech's new neuroscience building unites scientists, engineers to master the human brain
The Tianqiao and Chrissy Chen Institute for Neuroscience at the California Institute of Technology in Pasadena wins a Gold Award in BD+C's 2021 Building Team Awards.
Laboratories | Nov 17, 2021
New report finds a biopharma industry being reshaped by disruption
Industry respondents to CRB’s survey weigh in on project delivery, digitization, and off-site manufacturing for life sciences construction.